Skip to main content

Advertisement

SpringerLink
Log in

Serologic and Histologic Findings in Patients with Capsular Contracture After Breast Augmentation with Smooth Silicone Gel Implants: Is Serum Hyaluronan a Potential Predictor?

  • Published:
Aesthetic Plastic Surgery Aims and scope Submit manuscript

Abstract

Background

In this study, breast implant capsular tissues and blood samples from 25 cases were studied to characterize the relationship between capsular findings and serum analysis. The serum fibrosis indexes hyaluronan and the aminoterminal propeptide of procollagen type III (PIIINP) are fairly well correlated in several other studies with the inflammation grade and fibrosis in patients with progressive fibrotic disorders such as liver cirrhosis.

Methods

The study enrolled 25 female patients (average age, 40 ± 12 years) with capsular contracture after bilateral cosmetic breast augmentation using smooth silicone gel implants (Mentor). The implants were placed in a submuscular position through an incision in the inframammary fold. The implant removals were prompted by development of capsular fibrosis (Baker grades 1–4). Samples of capsular tissue were obtained from all the patients for standard histologic and immunohistochemical analyses. Blood samples were drawn from all the patients immediately before surgery. Sera from 20 healthy female patients (average age, 34 ± 9 years) who had undergone plastic surgery for reduction mammaplasty were used as controls.

Results

Histology. Capsular tissue was significantly thicker in patients with grades 3 and 4 contracture than in women with grade 2 contracture according the classification by Baker. There was a moderate (n = 15) or severe (n = 10) chronic inflammatory reaction in the capsules around the implants. Fibroblasts and macrophages represented the major cell population found in the fibrous capsules. In addition, activated CD4+ cells were detected. An inner layer with synovia-like metaplasia and multinucleated giant cells was found. Fibroblast-like cells formed the most common cell type in the capsules, along with macrophages, scattered polymorphonuclear leukocytes, lymphocytes, plasma cells, and mast cells. Serum analysis. There was a significantly higher level (p < 0.05) of hyaluronan serum concentration in patients with capsular contracture (26 ± 14 μg/l) than in control subjects (12 ± 6 μg/l). There was a positive correlation between the grade of capsular contracture (Baker 1–4) and the hyaluronan serum concentration (Baker 1–2: 15 ± 3 μg/l; Baker 3–4: 35 ± 12 μg/l) (r2 =0.73; p < 0.05).

Conclusion

: In this study, serum hyaluronan levels were significantly elevated in patients with constrictive fibrosis after breast augmentation, and there was a positive correlation with the stage of capsular contracture. Serum hyaluronan concentration may help in defining patients at risk for capsular fibrosis. If treatment with new drugs can be started as a preventive measure, it may be possible to reduce the rate of patients who require surgical intervention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Alfano C, Mazzocchi M, Scuderi N: Mammary compliance: An objective measurement of capsular contracture. Aesth Plast Surg28:75–79, 2004

    Article  Google Scholar 

  2. Baker JL Jr, Chandler ML, LeVier RR: Occurrence and activity of myofibroblasts in human capsular tissue surrounding mammary implants. Plast Reconstr Surg 68:905, 1981

    PubMed  Google Scholar 

  3. Baran CN, Peker F, Ortak T, Sensoz O, Baran NK: A different strategy in the surgical treatment of capsular contracture: Leave capsule intact. Aesth Plast Surg 25:427–431, 2001

    CAS  Google Scholar 

  4. Beekman WH, Hage JJ, Jorna LB, Mulder JW: Augmentation mammaplasty: The story before the silicone bag prosthesis. Ann Plast Surg 43:446–451, 1999

    PubMed  CAS  Google Scholar 

  5. Brody GS: On the safety of breast implants. Plast Reconstr Surg 100:1314–1321, 1997

    PubMed  CAS  Google Scholar 

  6. Brown SL, Pennello G, Berg WA, Soo MS, Middleton MS: Silicone gel breast implant rupture, extracapsular silicone, and health status in a population of women. J Rheumatol 28:996–1003, 2001

    PubMed  CAS  Google Scholar 

  7. Brunmark A, O’Rourke AM: Augmentation of mature CD44 cell response to isolated antigenic class II proteins by fibronectin and intercellular cell adhesion molecule-1. J Immunol 159:1676–1685, 1997

    PubMed  CAS  Google Scholar 

  8. Burckhardt BR: Capsular contracture: Hard breasts, soft data. Clin Plast Surg 15:521, 1988

    Google Scholar 

  9. Camirand A, Doucet J: Breast augmentation: Teaching our patients how compression can help prevent capsular contracture. Aesth Plast Surg 24:221–226, 2000

    Article  CAS  Google Scholar 

  10. Chiquet M: Regulation of extracellular matrix gene expression by mechanical stress. Matrix Biol 18:417–426, 1999

    Article  PubMed  CAS  Google Scholar 

  11. Cimons M: FDA plans safety reviews of several medical devices. Los Angeles Times, April 28, 1992, A-14

  12. Cunningham B: Update on situation of breast implants in the U.S. Presented at EQUAM’s 3rd Consensus Conference, Regensburg, Germany, 1998

  13. Deapen DM, Bestein L, Brody GS: Are breast implants anticarcinogenic? A 14-year–follow-up of the Los Angeles Study. Plast Reconst Surg 5:1346–1353, 1997

    Google Scholar 

  14. Dolores W, Rainer C, Niederegger H, Piza H, Wick G: Cellular and molecular composition of fibrous capsules formed around silicone breast implants with special focus on local immune reactions. J Autoimmunity 23:81–91, 2004

    Article  CAS  Google Scholar 

  15. Embrey M, Adams EE, Cunningham B, Peters W, Young VL, Carlo GL: A review of the literature on the aetiology of capsular contracture and a pilot study to determine the outcome of capsular contracture interventions. Aesth Plast Surg 23:197–206, 1999

    CAS  Google Scholar 

  16. European Commission: Guidelines for conformity assessment of breast implants according to directive, 93/42/EEC relating to medical devices. European Commission. Directorate—General III Industry, Brussels, July 1998

  17. Frangou J, Kanellaki M: The effect of local application of mitomycin-C on the development of capsule around silicone implants in the breast: An experimental study in mice. Aesth Plast Surg 25:118–128, 2001

    Article  CAS  Google Scholar 

  18. Gabriel SE, et al.: Complications leading to surgery after breast implantation. N Engl J Med 336:677–682, 1997

    Article  PubMed  CAS  Google Scholar 

  19. Gerszten PC: A formal risk assessment of silicone breast implants. Biomaterial 20:1063–1069, 1999

    Article  CAS  Google Scholar 

  20. Grigg M, Bondurand S, Ernster VL, Herdman R: Information for women about the safety of silicone breast implants. Report of the Institute of Medicine, Washington DC, June 1999

  21. Gylbert L, Asplund O, Jurell G: Capsular contracture after breast reconstruction with silicone- and saline-filled implants: A 6-year follow-up. Plast Reconstr Surg 86:809–811, 1990

    Google Scholar 

  22. Heppleston AG, Styles JA, cited by Carr I: The macrophage. Academic Press: London, 1973,84

  23. Karlson EW, Hankinson SE, Liang MH, Sanchez-Guerrero J, Colditz GA, Rosenau BJ, et al.: Association of silicone breast implants with immunologic abnormalities: A prospective study. Am J Med 106:11–19, 1999

    Article  PubMed  CAS  Google Scholar 

  24. Knudson W: The role of CD44 as a cell surface hyaluronan receptor during tumor invasion and metastasis. Frontiers Biosci 3:604–615, 1998

    Google Scholar 

  25. Kumari K, Weigel PH: Molecular cloning, expression, and characterization of the authentic hyaluronan synthase form group C Streptococcus equisimilis. J Biol Chem 272:32539–32546, 1997

    Article  PubMed  CAS  Google Scholar 

  26. Lossing C, Hansson H-A: Peptide growth factors and myofibroblasts in capsules around human breast implants. Plast Reconstr Surg 91:1277, 1993

    PubMed  CAS  Google Scholar 

  27. Markovitz M, Cifonelli JA, Dorfman A: The biosynthesis of hyaluronic acid by group A streptococcus: VI. Biosynthesis from uridine nucleotides in cell-free extracts. J Biol Chem 234:2342–2350, 1959

    Google Scholar 

  28. Martin-Moreno J, Gorgojo L, Gonzales J, Wiesbaum W: Draft final report study: Health Risk Posed by Silicone Implants in General With a Special Attention to Breast Implants. European Commission Directorate General III Industry, Brussels, March 2000

  29. Maxwell GP, Lugston PA: Management of complications following augmentation mammaplasty. In: Georgeade GS, Riefkohl R, Levin LS (eds) Georgeade plastic, maxillofacial and reconstructive surgery. 3rd ed. Williams & Wilkins: Baltimore, MD, 1997

  30. Meyer K, Palmer JW: The polysaccharide of the vitreous humor. J Biol Chem 107:629–634, 1934

    CAS  Google Scholar 

  31. Neudecker BA, Stern R, Connolly MK: Aberrant serum hyaluronan and hyaluronidase levels in scleroderma. Br J Dermatol 150:469–476, 2004

    Article  PubMed  CAS  Google Scholar 

  32. Olivari N: Infection and capsular fibrosis. ISAPS 2004 postgraduate course, Berlin, March 2004

  33. Perschl A, Lesley J, English N, Trowbridge I, Hyman R: Role of CD44 cytoplasmic domain in hyaluronan binding. Eur J Immunol 25:495–501, 1995

    PubMed  CAS  Google Scholar 

  34. Peters WJ, Smith D, Lugowsky S: Failure properties of 352 explanted silicone implants: A report of 300 patients. Ann Plast Surg 34:3–6, 1995

    Google Scholar 

  35. Planas J, Cervelli V, Planas G: Five-year experience on ultrasonic treatment of breast contractures. Aesth Plast Surg 25:89–93, 2001

    Article  CAS  Google Scholar 

  36. Puckett CL: On the safety of silicone gel implants. Cancer Invest 18:278–280, 2000

    PubMed  CAS  Google Scholar 

  37. Rosenbaum D, Peric S, Holecek M, Ward HE: Hyaluronan in radiation-induced lung disease in the rat. Radiat Res 147:585, 1997

    PubMed  CAS  Google Scholar 

  38. Schmits R, et al.: CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 90:2217–2223, 1997

    PubMed  CAS  Google Scholar 

  39. Scott JE: Supramolecular organization of extracellular matrix glycosaminoglycans, in vitro and in the tissues. FASEB J 6:2639–2645, 1992

    PubMed  CAS  Google Scholar 

  40. Sergott TJ, Limoli JP, Baldwin CM, Laub DR: human adjuvant disease, possible autoimmune disease after silicone implantation. Plast Reconstr Surg 78:104–111, 1986

    PubMed  CAS  Google Scholar 

  41. Siggelkow W, Faridi A, Spiritus K, et al: Histological analysis of silicone breast implant capsules and correlation with capsular contracture. Biomaterials 24:1101, 2003

    Article  PubMed  CAS  Google Scholar 

  42. Sundstrom G, Lofvenberg E, Hassan I, Engstrom-Laurent A: Localisation and distribution of hyaluronan in normal bone marrow matrix: A novel method to evaluate impending fibrosis? Eur J Haematol 68:194, 2002

    Article  PubMed  CAS  Google Scholar 

  43. Takayanagi S, Nakagawa C, Sugimoto Y: Augmentation mammaplasty: Where should the implant be placed? Aesth Plast Surg 28:83–88, 2004

    Article  Google Scholar 

  44. Tao J, Peng HQ, Cai WM, Dong FQ, Weng HL, Liu RH: Influence factors of serum fibrosis markers in liver fibrosis. World J Gastroenterol 9:2497–2500, 2003

    PubMed  Google Scholar 

  45. Tenenbaum SA, Rice JC, Espinoza LR, Cuèllar ML, Plymale DR, Sander DM, et al.: Use of antipolymer antibody assay in recipients of silicone breast implants. Lancet 349:449–454, 1997

    PubMed  CAS  Google Scholar 

  46. Tugwell P, Wells G, Peterson J, Welch V, Page J, Davison C, et al.: Do silicone breast implants cause rheumatologic disorders? A systemic review for a court-appointed national science panel. Arthritis Rheum 44:2477–2484, 2001

    Article  PubMed  CAS  Google Scholar 

  47. Tuhkanen A-L, Tammi M, Tammi R: CD44 substituted with heparan sulfate and endo-beta-galactosidase-sensitive oligosaccharides: A major proteoglycan in adult human epidermis. J Invest Dermatol 109:213–218, 1997

    Article  PubMed  CAS  Google Scholar 

  48. Ulrich D, Noah EM, Burchardt ER, Atkins D, Pallua N: Serum concentration of aminoterminal propeptide of type III procollagen (PIIINP) as a prognostic marker of skin fibrosis after scar correction in burned patients. Burns 28:766, 2002

    Article  PubMed  Google Scholar 

  49. Ulrich D, Noah EM, von Heimburg D, Pallua N: TIMP-1, MMP-2, -9, and PIIINP as serum markers for skin fibrosis in patients following severe burn trauma. Plast Reconstr Surg 111:1423, 2003

    PubMed  Google Scholar 

  50. Vasquez B, Given KS, Housten GC: Breast augmentation: Review of subglandular and submascular implantation. Aesth Plast Surg 11:101–105, 1987

    Google Scholar 

  51. Weissmann B, Meyer K: The structure of hyalobiuronic acid and of hyaluronic acid from umbilical cord. J Am Chem Soc 76:1753–1757, 1954

    Article  CAS  Google Scholar 

  52. Wells AF, Daniels S, Gunasekaran S, Wells KE: Local increase in hyaluronic acid and interleukin-2 in the capsules surrounding silicone breast implants. Ann Plast Surg 33:1–5, 1994

    PubMed  CAS  Google Scholar 

  53. Wick G, Wagner R, Klima G, Wilfingseder P: Immunohistochemical analysis of the connective tissue capsule formation and constriction around mammary silicone prostheses. In: Kano K, Mori S, Sugisaki T, Torisu M (ed) Cellular, molecular, and genetic approaches to immunodiagnosis and immunotherapy. University of Tokyo Press. pp. 231–241, 1987

  54. Wyatt HA, Dhawan A, Cheeseman P, Mieli-Vergani G, Price JF: Serum hyaluronic acid concentrations are increased in cystic fibrosis patients with liver disease. Arch Dis Child 86:190–193, 2002

    Article  PubMed  CAS  Google Scholar 

  55. Wyatt Lance E, Sinow J, Wollman JS, Sami DABS, Miller TA: The influence of time on human breast capsule histology: Smooth and textured silicone-surfaced implants. Plast Reconstr Surg 102:1922–1931, 1998

    Google Scholar 

  56. Xie SB, Yao JL, Zheng RQ, Peng XM, Gao ZL: Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis. Hepatobiliary Pancreat Dis Int 2:69–72, 2003

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. EBOPRAS Diplomate, Department of Plastic Surgery, University of Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, G-93042, Germany

    L. Prantl M.D., N. Pöppl M.D., N. Horvat M.D., N. Heine M.D. & M. Eisenmann-Klein M.D.

Authors
  1. L. Prantl M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Pöppl M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Horvat M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. Heine M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Eisenmann-Klein M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. Prantl M.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prantl, L., Pöppl, N., Horvat, N. et al. Serologic and Histologic Findings in Patients with Capsular Contracture After Breast Augmentation with Smooth Silicone Gel Implants: Is Serum Hyaluronan a Potential Predictor?. Aesth Plast Surg 29, 510–518 (2005). https://doi.org/10.1007/s00266-005-5049-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00266-005-5049-y

Keywords

Search

Navigation